ARCHIVES

Drugs and Targets: FDA extends Lymphoseek label to include mapping in solid tumors

This article is from The Cancer Letter archive.

Vol. 40 No. 41 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Responses To Control Grants Guidelines Pour Into NCI, Some From Grantsmen “Old Pros”

November 23, 1974

World Conference To Consider Smoking Problem, Research, Action

March 14, 1975

BMS Agent Yervoy Received FDA Approval for Metastatic Melanoma

March 25, 2011

Brown Needs Decision By March 31; Sander Decline HEW Offer

March 4, 1977

VTP Implementing 95% Of Ad Hoc Panel Suggestions

May 10, 1985

AACR’s Elion Award Invites Applicants

December 10, 1993